218 related articles for article (PubMed ID: 22237010)
1. Increased cancer risks in myotonic dystrophy.
Win AK; Perattur PG; Pulido JS; Pulido CM; Lindor NM
Mayo Clin Proc; 2012 Feb; 87(2):130-5. PubMed ID: 22237010
[TBL] [Abstract][Full Text] [Related]
2. Cancer phenotype in myotonic dystrophy patients: Results from a meta-analysis.
Emparanza JI; López de Munain A; Greene MH; Matheu A; Fernández-Torrón R; Gadalla SM
Muscle Nerve; 2018 Oct; 58(4):517-522. PubMed ID: 30028904
[TBL] [Abstract][Full Text] [Related]
3. A population-based survey of risk for cancer in individuals diagnosed with myotonic dystrophy.
Abbott D; Johnson NE; Cannon-Albright LA
Muscle Nerve; 2016 Oct; 54(4):783-5. PubMed ID: 27064430
[TBL] [Abstract][Full Text] [Related]
4. Brain tumors in patients with myotonic dystrophy: a population-based study.
Gadalla SM; Pfeiffer RM; Kristinsson SY; Björkholm M; Landgren O; Greene MH
Eur J Neurol; 2016 Mar; 23(3):542-7. PubMed ID: 26508558
[TBL] [Abstract][Full Text] [Related]
5. Cancer risk among patients with myotonic muscular dystrophy.
Gadalla SM; Lund M; Pfeiffer RM; Gørtz S; Mueller CM; Moxley RT; Kristinsson SY; Björkholm M; Shebl FM; Hilbert JE; Landgren O; Wohlfahrt J; Melbye M; Greene MH
JAMA; 2011 Dec; 306(22):2480-6. PubMed ID: 22166607
[TBL] [Abstract][Full Text] [Related]
6. Cancer risk in systemic lupus: an updated international multi-centre cohort study.
Bernatsky S; Ramsey-Goldman R; Labrecque J; Joseph L; Boivin JF; Petri M; Zoma A; Manzi S; Urowitz MB; Gladman D; Fortin PR; Ginzler E; Yelin E; Bae SC; Wallace DJ; Edworthy S; Jacobsen S; Gordon C; Dooley MA; Peschken CA; Hanly JG; Alarcón GS; Nived O; Ruiz-Irastorza G; Isenberg D; Rahman A; Witte T; Aranow C; Kamen DL; Steinsson K; Askanase A; Barr S; Criswell LA; Sturfelt G; Patel NM; Senécal JL; Zummer M; Pope JE; Ensworth S; El-Gabalawy H; McCarthy T; Dreyer L; Sibley J; St Pierre Y; Clarke AE
J Autoimmun; 2013 May; 42():130-5. PubMed ID: 23410586
[TBL] [Abstract][Full Text] [Related]
7. Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulation.
Fernández-Torrón R; García-Puga M; Emparanza JI; Maneiro M; Cobo AM; Poza JJ; Espinal JB; Zulaica M; Ruiz I; Martorell L; Otaegui D; Matheu A; López de Munain A
Neurology; 2016 Sep; 87(12):1250-7. PubMed ID: 27558368
[TBL] [Abstract][Full Text] [Related]
8. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
Hisada M; Chen BE; Jaffe ES; Travis LB
J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
[TBL] [Abstract][Full Text] [Related]
9. Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.
Win AK; Lindor NM; Young JP; Macrae FA; Young GP; Williamson E; Parry S; Goldblatt J; Lipton L; Winship I; Leggett B; Tucker KM; Giles GG; Buchanan DD; Clendenning M; Rosty C; Arnold J; Levine AJ; Haile RW; Gallinger S; Le Marchand L; Newcomb PA; Hopper JL; Jenkins MA
J Natl Cancer Inst; 2012 Sep; 104(18):1363-72. PubMed ID: 22933731
[TBL] [Abstract][Full Text] [Related]
10. Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome.
Win AK; Lindor NM; Winship I; Tucker KM; Buchanan DD; Young JP; Rosty C; Leggett B; Giles GG; Goldblatt J; Macrae FA; Parry S; Kalady MF; Baron JA; Ahnen DJ; Marchand LL; Gallinger S; Haile RW; Newcomb PA; Hopper JL; Jenkins MA
J Natl Cancer Inst; 2013 Feb; 105(4):274-9. PubMed ID: 23385444
[TBL] [Abstract][Full Text] [Related]
11. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
Wu GX; Nelson RA; Kim JY; Raz DJ
Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
[TBL] [Abstract][Full Text] [Related]
12. Survival patterns and cancer determinants in families with myotonic dystrophy type 1.
Best AF; Hilbert JE; Wood L; Martens WB; Nikolenko N; Marini-Bettolo C; Lochmüller H; Rosenberg PS; Moxley RT; Greene MH; Gadalla SM
Eur J Neurol; 2019 Jan; 26(1):58-65. PubMed ID: 30051542
[TBL] [Abstract][Full Text] [Related]
13. Cardiac involvement in myotonic dystrophy: a nationwide cohort study.
Lund M; Diaz LJ; Ranthe MF; Petri H; Duno M; Juncker I; Eiberg H; Vissing J; Bundgaard H; Wohlfahrt J; Melbye M
Eur Heart J; 2014 Aug; 35(32):2158-64. PubMed ID: 24742887
[TBL] [Abstract][Full Text] [Related]
14. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
15. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
Teng CJ; Hu YW; Chen SC; Yeh CM; Chiang HL; Chen TJ; Liu CJ
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26538627
[TBL] [Abstract][Full Text] [Related]
16. Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink.
Wang Y; Pfeiffer RM; Alsaggaf R; Meeraus W; Gage JC; Anderson LA; Bremer RC; Nikolenko N; Lochmuller H; Greene MH; Gadalla SM
Int J Cancer; 2018 Mar; 142(6):1174-1181. PubMed ID: 29114849
[TBL] [Abstract][Full Text] [Related]
17. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
18. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
19. Benign tumors in myotonic dystrophy type I target disease-related cancer sites.
Alsaggaf R; St George DMM; Zhan M; Pfeiffer RM; Wang Y; Anderson LA; Liu Z; Koshiol J; Bauer AJ; Wagner KR; Greene MH; Amr S; Gadalla SM
Ann Clin Transl Neurol; 2019 Aug; 6(8):1510-1518. PubMed ID: 31402615
[TBL] [Abstract][Full Text] [Related]
20. Acromegaly and cancer risk: a cohort study in Sweden and Denmark.
Baris D; Gridley G; Ron E; Weiderpass E; Mellemkjaer L; Ekbom A; Olsen JH; Baron JA; Fraumeni JF
Cancer Causes Control; 2002 Jun; 13(5):395-400. PubMed ID: 12146843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
